CASSANDRA BROWN: Open Payments
NPI 1487214151 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 12 payments from 9 companies in 2025. Trend: 2023 $2,350 · 2024 $1,021 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $235 |
| Medtronic, Inc. | 2 | $143 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Actelion Pharmaceuticals US, Inc. | 1 | $109 |
| Lilly USA, LLC | 1 | $98 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Smith+Nephew, Inc. | 2 | $48 |
Products named: REXULTI, COBALT DR MRI SURESCAN, CAPLYTA, CAMZYOS, LOKELMA, UPTRAVI, ZEPBOUND, BIOBRANE.
Industry payments across GA — which companies pay providers there.
